Autoantibodies as potential biomarkers of high grade immune-related adverse events (irAEs) in metastatic melanoma patients treated with check point inhibitors (ICIs)

A. Gandhi; J. Taylor; M. Morici; A. Reid; T. Meniawy; M. A. Khattak; M. Millward; E. S. Gray; P. Zaenker

doi:10.1016/j.annonc.2022.07.162

Autoantibodies as potential biomarkers of high grade immune-related adverse events (irAEs) in metastatic melanoma patients treated with check point inhibitors (ICIs)

A. Gandhi, J. Taylor, M. Morici, A. Reid, T. Meniawy, M. A. Khattak, M. Millward, E. S. Gray, P. Zaenker

Internal Medicine

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S597-S597
Number of pages	1
Journal	Annals of Oncology
Volume	33
Issue number	7
DOIs	https://doi.org/10.1016/j.annonc.2022.07.162
Publication status	Published - Sept 2022
Event	2022 Annual Meeting of the European-Society-for-Medical-Oncology - , France Duration: 9 Sept 2022 → 13 Sept 2022

Access to Document

10.1016/j.annonc.2022.07.162

Cite this

Gandhi, A., Taylor, J., Morici, M., Reid, A., Meniawy, T., Khattak, M. A., Millward, M., Gray, E. S., & Zaenker, P. (2022). Autoantibodies as potential biomarkers of high grade immune-related adverse events (irAEs) in metastatic melanoma patients treated with check point inhibitors (ICIs). Annals of Oncology, 33(7), S597-S597. https://doi.org/10.1016/j.annonc.2022.07.162

@article{90a1439e3e2f4da6a08b5562aa288c20,

title = "Autoantibodies as potential biomarkers of high grade immune-related adverse events (irAEs) in metastatic melanoma patients treated with check point inhibitors (ICIs)",

author = "A. Gandhi and J. Taylor and M. Morici and A. Reid and T. Meniawy and Khattak, {M. A.} and M. Millward and Gray, {E. S.} and P. Zaenker",

year = "2022",

month = sep,

doi = "10.1016/j.annonc.2022.07.162",

language = "English",

volume = "33",

pages = "S597--S597",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "7",

note = "2022 Annual Meeting of the European-Society-for-Medical-Oncology, ESMO 2022 ; Conference date: 09-09-2022 Through 13-09-2022",

}

Gandhi, A, Taylor, J, Morici, M, Reid, A, Meniawy, T, Khattak, MA, Millward, M, Gray, ES & Zaenker, P 2022, 'Autoantibodies as potential biomarkers of high grade immune-related adverse events (irAEs) in metastatic melanoma patients treated with check point inhibitors (ICIs)', Annals of Oncology, vol. 33, no. 7, pp. S597-S597. https://doi.org/10.1016/j.annonc.2022.07.162

TY - JOUR

T1 - Autoantibodies as potential biomarkers of high grade immune-related adverse events (irAEs) in metastatic melanoma patients treated with check point inhibitors (ICIs)

AU - Gandhi, A.

AU - Taylor, J.

AU - Morici, M.

AU - Reid, A.

AU - Meniawy, T.

AU - Khattak, M. A.

AU - Millward, M.

AU - Gray, E. S.

AU - Zaenker, P.

PY - 2022/9

Y1 - 2022/9

U2 - 10.1016/j.annonc.2022.07.162

DO - 10.1016/j.annonc.2022.07.162

M3 - Abstract/Meeting Abstract

SN - 0923-7534

VL - 33

SP - S597-S597

JO - Annals of Oncology

JF - Annals of Oncology

IS - 7

T2 - 2022 Annual Meeting of the European-Society-for-Medical-Oncology

Y2 - 9 September 2022 through 13 September 2022

ER -